CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on: June 12,2024 5

CDC: Prevalence of any past, present hep B infection 4.3 percent

(HealthDay)—The prevalence of any past or present hepatitis B virus (HBV) infection was 4.3 percent among U.S. adults during 2015 to 2018, according to a March data brief published by the U.S. Centers

Updated on:June 12,2024 5

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on: June 03,2024 8

Scientists find omega-3 lysolipids may prevent fatty liver disease

by Duke-NUS Medical SchoolDetection of the lysolipid transporter Mfsd2a in hepatocytes, stained green, in proximity to a bile duct, stained magenta. Credit: Chin Cheen FeiLong-running research by

Updated on:June 03,2024 8

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on: June 12,2024 4

Acute pancreatitis may progress to chronic with sustained heavy alcohol use

by Lori SolomonMany patients with recurrent acute pancreatitis (RAP) and acute pancreatitis (AP) have high lifetime cumulative drinking and heavy daily alcohol use, suggesting disease progression towa

Updated on:June 12,2024 4

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on: September 10,2024 0

Finding new targets for blocking chronic hepatitis

byTokyo Medical and Dental UniversityLoss of A20 function in hepatic stellate cells upregulated the DCLK1-JNK phosphorylation axis. DCLK1 enhances chemokine expression, leading to progression of

Updated on:September 10,2024 0

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on: May 29,2024 7

Immune therapies against chronic hepatitis B

by Ehime UniversityTwo main types of immune therapies have been employed to treat chronic hepatitis B during the last 4 decades. However, it seems that HBV-antigen-specific immune therapy may be safe

Updated on:May 29,2024 7

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit

Updated on: July 11,2024 0

Microproteins exclusively produced in liver tumors could lead to cancer vaccines

by IMIM (Hospital del Mar Medical Research Institute)Credit: Pixabay/CC0 Public DomainA study led by the Hospital del Mar Research Institute, with Cima University of Navarra and Pompeu Fabra Universit

Updated on:July 11,2024 0

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p

Updated on: June 04,2024 6

Study shows seladelpar beneficial for patients with primary biliary cholangitis

by Elana GotkineFor patients with primary biliary cholangitis, more receiving the peroxisome proliferator-activated receptor delta (PPARδ) agonist seladelpar have a biochemical response and alkaline p

Updated on:June 04,2024 6

What Is Hepatomegaly?

What Is Hepatomegaly?ByRony Kampalath, MDUpdated on May 04, 2023Medically reviewed bySonal Kumar, MDHepatomegalyis an enlarged liver, which may be caused by a variety of

Updated on: July 01,2024 0

What Is Hepatomegaly?

What Is Hepatomegaly?ByRony Kampalath, MDUpdated on May 04, 2023Medically reviewed bySonal Kumar, MDHepatomegalyis an enlarged liver, which may be caused by a variety of

Updated on:July 01,2024 0

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.

Updated on: May 29,2024 4

Gut microbiota harnessed as tool to diagnose diseases, promising results for fatty liver diagnosis

by University of JyväskyläThe diversity of the gut microbiota in the low (n = 25) and high (n = 37) liver fat groups. (A) Shannon index, a measure of alpha-diversity indicating species diversity.

Updated on:May 29,2024 4

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on: June 20,2024 6

Liver cancer 'signature' in gut holds clues to cancer risk

by Caroline Tang,University of New South WalesCredit: Thirdman from PexelsPeople with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk,

Updated on:June 20,2024 6

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on: July 19,2024 0

Exploring the pathogenesis of autoimmune liver diseases from the heterogeneity of target cells

by Xia & He Publishing Inc.Hepatoblasts differentiate into hepatocytes, large and small cholangiocytes. CK8, CK18, and CK19 are expressed in hepatoblasts. CK8 and CK18 are expressed in hepatocytes

Updated on:July 19,2024 0

What Are Liver Flukes?

What Are Liver Flukes?Parasitic Worms That Cause InfectionsByMichelle PuglePublished on March 22, 2023Medically reviewed byRochelle Collins, DOLiver flukes are parasitic worms

Updated on: July 01,2024 0

What Are Liver Flukes?

What Are Liver Flukes?Parasitic Worms That Cause InfectionsByMichelle PuglePublished on March 22, 2023Medically reviewed byRochelle Collins, DOLiver flukes are parasitic worms

Updated on:July 01,2024 0